NUTRA PHARMA CORP Quarterly Nonoperating Income (Expense) in USD from Q1 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Nutra Pharma Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2011 to Q3 2022.
  • Nutra Pharma Corp Nonoperating Income (Expense) for the quarter ending September 30, 2022 was $814K, a 94.9% decline year-over-year.
  • Nutra Pharma Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was $8.45M.
  • Nutra Pharma Corp annual Nonoperating Income (Expense) for 2021 was -$11.1M, a 7231% decline from 2020.
  • Nutra Pharma Corp annual Nonoperating Income (Expense) for 2020 was $156K.
  • Nutra Pharma Corp annual Nonoperating Income (Expense) for 2019 was -$5.36M, a 167% decline from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $8.45M $814K -$15.1M -94.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $23.6M -$305K -$4.11M -108% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-22
Q1 2022 $27.7M $5.32M +$38.8M Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-20
Q4 2021 -$11.1M $2.62M +$4.3M Oct 1, 2021 Dec 31, 2021 10-K 2022-04-15
Q3 2021 -$15.4M $15.9M +$15.2M +1967% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$30.6M $3.8M +$5.11M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$35.7M -$33.5M -$35.8M -1512% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-20
Q4 2020 $156K -$1.68M +$1.94M +53.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$1.78M $772K +$1.02M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$2.81M -$1.31M +$32.7K +2.44% Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-24
Q1 2020 -$2.84M $2.37M +$2.52M Jan 1, 2020 Mar 31, 2020 10-Q 2021-09-17
Q4 2019 -$5.36M -$3.62M Oct 1, 2019 Dec 31, 2019 10-K 2021-09-08
Q3 2019 -$252K -$138K -122% Jul 1, 2019 Sep 30, 2019 10-Q 2021-08-12
Q2 2019 -$1.34M Apr 1, 2019 Jun 30, 2019 10-Q 2021-08-05
Q1 2019 -$152K Jan 1, 2019 Mar 31, 2019 10-Q 2021-07-23
Q3 2018 -$114K Jul 1, 2018 Sep 30, 2018 10-Q 2021-05-14
Q1 2014 -$1.82M $21K +$162K Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-20
Q4 2013 -$1.98M $513K +$1.11M Oct 1, 2013 Dec 31, 2013 10-K 2014-03-31
Q3 2013 -$3.09M -$2.1M -$2M -2051% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-19
Q2 2013 -$1.09M -$251K -$299K -614% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-19
Q1 2013 -$790K -$141K +$221K +61% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$1.01M -$600K -$126K -26.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$885K -$97.8K -$105K -1464% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-19
Q2 2012 -$780K $48.8K +$9.27K +23.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-19
Q1 2012 -$789K -$363K -$343K -1713% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-20
Q4 2011 -$447K -$473K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-16
Q3 2011 $7.17K Jul 1, 2011 Sep 30, 2011 10-Q/A 2012-12-12
Q2 2011 $39.5K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-12-07
Q1 2011 -$20K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-11-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.